15 Biggest Mid-Day Losers For Wednesday

xG Technology Inc XGTI shares dropped 54.4 percent to $1.65 after the company reported the pricing of its $10 million offering.
Modsys International Ltd MDSY shares tumbled 18 percent to $0.992. Modsys shares have dipped 40.64 percent over the past 52 weeks, while the S&P 500 index has gained 12.35 percent in the same period.
Merrimack Pharmaceuticals Inc MACK declined 17.9 percent to $4.41 after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
Vanguard Natural Resources, LLC VNR shares fell 15.8 percent to $0.850. Vanguard Natural shares have declined 63.54 percent over the past 52 weeks, while the S&P 500 index has gained 12.35 percent in the same period.
ContraVir Pharmaceuticals Inc CTRV shares dropped 13.3 percent to $1.47.
Finish Line Inc FINL shares tumbled 12 percent to $20.25 after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
Long Island Iced Tea Corp LTEA shares dipped 11.8 percent to $4.20. Long Island Iced Tea priced an underwritten public offering of 399,050 shares at $4.00 per share.
RedHill Biopharma Ltd - ADR RDHL declined 10.6 percent to $9.66. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
Lindsay Corporation LNN shares dropped 9 percent to $77.63 after the company posted downbeat Q1 results.
Delcath Systems, Inc. DCTH shares fell 9 percent to $1.11. Delcath Systems shares have dropped 86.14 percent over the past 52 weeks, while the S&P 500 index has increased 12.35 percent in the same period.
Advanced Accelerator Application SA(ADR) AAAP shares declined 5.4 percent to $24.79 after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
Accenture Plc ACN fell 4.2 percent to $118.95 after the company issued a weak outlook for the full year.
New York Community Bancorp, Inc. NYCB shares dropped 4.2 percent to $16.05. FBR Capital, Morgan Stanley and Raymond James downgraded New York Community Bancorp.
Lexicon Pharmaceuticals, Inc. LXRX shares slipped 3.4 percent to $15.78 after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
FedEx Corporation FDX fell 2.6 percent to $193.60 after the company reported weaker-than-expected earnings for its second quarter on Tuesday.

Market News and Data brought to you by Benzinga APIs

Comments

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga